{"t": "Chapter 29 Drug Therapy Management", "p": "/us/md/exec/comar/10.34.29", "et": "container", "dj": "/us/md/exec/comar/index.json", "fh": "/us/md/exec/comar/10.34.29/index.full.html", "sc": "10.34.29", "rp": "10|34|29", "sp": "library|Code of Maryland Regulations|10|34|29", "c": [{"t": ".01 Definitions.", "p": "/us/md/exec/comar/10.34.29.01", "et": "section", "sc": "10.34.29.01", "rp": "10|34|29|.01", "sp": "library|Code of Maryland Regulations|10|34|29|.01", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.01#A", "et": "para", "sc": "10.34.29.01A", "rp": "10|34|29|.01|A.", "x": "In this chapter, the following terms have the meanings indicated."}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.01#B", "et": "para", "sc": "10.34.29.01B", "rp": "10|34|29|.01|B.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.01#B(1)", "et": "para", "sc": "10.34.29.01B(1)", "rp": "10|34|29|.01|B.|(1)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.01#B(1)(a)", "et": "para", "sc": "10.34.29.01B(1)(a)", "rp": "10|34|29|.01|B.|(1)|(a)", "x": "A protocol or prescriber-pharmacist agreement; or"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.01#B(1)(b)", "et": "para", "sc": "10.34.29.01B(1)(b)", "rp": "10|34|29|.01|B.|(1)|(b)", "x": "The parties to the prescriber-pharmacist agreement."}], "x": "\u201cAmendment\u201d means a change to:"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.01#B(2)", "et": "para", "sc": "10.34.29.01B(2)", "rp": "10|34|29|.01|B.|(2)", "x": "\u201cApplicants\u201d means physicians, pharmacists, podiatrists, or certified advan"}, {"t": "(2-1)", "p": "/us/md/exec/comar/10.34.29.01#B(2-1)", "et": "para", "sc": "10.34.29.01B(2-1)", "rp": "10|34|29|.01|B.|(2-1)", "x": "\u201cAuthorized prescriber\u201d means a licensed physician, licensed podiatrist, or"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.01#B(3)", "et": "para", "sc": "10.34.29.01B(3)", "rp": "10|34|29|.01|B.|(3)", "x": "\u201cBoards\u201d means the Board of Physicians, the Board of Pharmacy, the Board of"}, {"t": "(4)", "p": "/us/md/exec/comar/10.34.29.01#B(4)", "et": "para", "sc": "10.34.29.01B(4)", "rp": "10|34|29|.01|B.|(4)", "x": "\"Condition\" means a disease-state or health circumstance necessitating moni"}, {"t": "(5)", "p": "/us/md/exec/comar/10.34.29.01#B(5)", "et": "para", "sc": "10.34.29.01B(5)", "rp": "10|34|29|.01|B.|(5)", "x": "\"Emergency first care\" means triage of emergent conditions or treatment of "}], "x": "Terms Defined."}]}, {"t": ".02 Content of Protocol.", "p": "/us/md/exec/comar/10.34.29.02", "et": "section", "sc": "10.34.29.02", "rp": "10|34|29|.02", "sp": "library|Code of Maryland Regulations|10|34|29|.02", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.02#A", "et": "para", "sc": "10.34.29.02A", "rp": "10|34|29|.02|A.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.02#A(1)", "et": "para", "sc": "10.34.29.02A(1)", "rp": "10|34|29|.02|A.|(1)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.02#A(1)(a)", "et": "para", "sc": "10.34.29.02A(1)(a)", "rp": "10|34|29|.02|A.|(1)|(a)", "x": "Written; and"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.02#A(1)(b)", "et": "para", "sc": "10.34.29.02A(1)(b)", "rp": "10|34|29|.02|A.|(1)|(b)", "x": "Condition or disease-state specific; and"}], "x": "Be:"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.02#A(2)", "et": "para", "sc": "10.34.29.02A(2)", "rp": "10|34|29|.02|A.|(2)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(a)", "et": "para", "sc": "10.34.29.02A(2)(a)", "rp": "10|34|29|.02|A.|(2)|(a)", "x": "The condition that the protocol is designed to manage;"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(b)", "et": "para", "sc": "10.34.29.02A(2)(b)", "rp": "10|34|29|.02|A.|(2)|(b)", "x": "A list of medications that may be used under the auspices of the protocol;"}, {"t": "(c)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(c)", "et": "para", "sc": "10.34.29.02A(2)(c)", "rp": "10|34|29|.02|A.|(2)|(c)", "c": [{"t": "(i)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(c)(i)", "et": "para", "sc": "10.34.29.02A(2)(c)(i)", "rp": "10|34|29|.02|A.|(2)|(c)|(i)", "x": "Condition; and"}, {"t": "(ii)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(c)(ii)", "et": "para", "sc": "10.34.29.02A(2)(c)(ii)", "rp": "10|34|29|.02|A.|(2)|(c)|(ii)", "x": "Medication employed;"}], "x": "Monitoring parameters including laboratory tests for the:"}, {"t": "(d)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(d)", "et": "para", "sc": "10.34.29.02A(2)(d)", "rp": "10|34|29|.02|A.|(2)|(d)", "x": "A list of circumstances requiring contact with the authorized prescriber or"}, {"t": "(e)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(e)", "et": "para", "sc": "10.34.29.02A(2)(e)", "rp": "10|34|29|.02|A.|(2)|(e)", "x": "A statement prohibiting substitution of a chemically dissimilar drug produc"}, {"t": "(f)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(f)", "et": "para", "sc": "10.34.29.02A(2)(f)", "rp": "10|34|29|.02|A.|(2)|(f)", "x": "A list of circumstances under which the pharmacist may alter doses, modify "}, {"t": "(g)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(g)", "et": "para", "sc": "10.34.29.02A(2)(g)", "rp": "10|34|29|.02|A.|(2)|(g)", "x": "Information to be documented;"}, {"t": "(h)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(h)", "et": "para", "sc": "10.34.29.02A(2)(h)", "rp": "10|34|29|.02|A.|(2)|(h)", "x": "A listing of provisions within the protocol that may be customized within a"}, {"t": "(i)", "p": "/us/md/exec/comar/10.34.29.02#A(2)(i)", "et": "para", "sc": "10.34.29.02A(2)(i)", "rp": "10|34|29|.02|A.|(2)|(i)", "x": "An action plan for situations when the pharmacist encounters a situation th"}], "x": "Contain the following:"}], "x": "A protocol shall:"}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.02#B", "et": "para", "sc": "10.34.29.02B", "rp": "10|34|29|.02|B.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.02#B(1)", "et": "para", "sc": "10.34.29.02B(1)", "rp": "10|34|29|.02|B.|(1)", "x": "The modification, continuation, and discontinuation of drug therapy;"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.02#B(2)", "et": "para", "sc": "10.34.29.02B(2)", "rp": "10|34|29|.02|B.|(2)", "x": "The ordering of laboratory tests;"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.02#B(3)", "et": "para", "sc": "10.34.29.02B(3)", "rp": "10|34|29|.02|B.|(3)", "x": "Other patient care management measures related to monitoring or improving t"}, {"t": "(4)", "p": "/us/md/exec/comar/10.34.29.02#B(4)", "et": "para", "sc": "10.34.29.02B(4)", "rp": "10|34|29|.02|B.|(4)", "x": "For protocols by a licensed physician and licensed pharmacist, the initiati"}], "x": "A protocol may authorize:"}, {"t": "C.", "p": "/us/md/exec/comar/10.34.29.02#C", "et": "para", "sc": "10.34.29.02C", "rp": "10|34|29|.02|C.", "x": "A protocol may not authorize acts that exceed the scope of practice of the "}, {"t": "D.", "p": "/us/md/exec/comar/10.34.29.02#D", "et": "para", "sc": "10.34.29.02D", "rp": "10|34|29|.02|D.", "x": "Technical modifications to the protocol shall be registered with the Board "}]}, {"t": ".03 Content of Prescriber-Pharmacist Agreement.", "p": "/us/md/exec/comar/10.34.29.03", "et": "section", "sc": "10.34.29.03", "rp": "10|34|29|.03", "sp": "library|Code of Maryland Regulations|10|34|29|.03", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.03#A", "et": "para", "sc": "10.34.29.03A", "rp": "10|34|29|.03|A.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.03#A(1)", "et": "para", "sc": "10.34.29.03A(1)", "rp": "10|34|29|.03|A.|(1)", "x": "The names and signatures of the physicians, podiatrists, or certified advan"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.03#A(2)", "et": "para", "sc": "10.34.29.03A(2)", "rp": "10|34|29|.03|A.|(2)", "x": "The locations where the pharmacists may provide therapy management services"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.03#A(3)", "et": "para", "sc": "10.34.29.03A(3)", "rp": "10|34|29|.03|A.|(3)", "x": "The titles of the protocols to which the prescriber-pharmacist agreement pe"}, {"t": "(4)", "p": "/us/md/exec/comar/10.34.29.03#A(4)", "et": "para", "sc": "10.34.29.03A(4)", "rp": "10|34|29|.03|A.|(4)", "x": "The methods and time frames by which documentation and routine communicatio"}, {"t": "(5)", "p": "/us/md/exec/comar/10.34.29.03#A(5)", "et": "para", "sc": "10.34.29.03A(5)", "rp": "10|34|29|.03|A.|(5)", "x": "The name, address, and telephone number of the party to the prescriber-phar"}, {"t": "(6)", "p": "/us/md/exec/comar/10.34.29.03#A(6)", "et": "para", "sc": "10.34.29.03A(6)", "rp": "10|34|29|.03|A.|(6)", "x": "A statement that the physicians, podiatrists, or certified advanced practic"}, {"t": "(7)", "p": "/us/md/exec/comar/10.34.29.03#A(7)", "et": "para", "sc": "10.34.29.03A(7)", "rp": "10|34|29|.03|A.|(7)", "x": "A list of devices available to the pharmacists performing under the prescri"}], "x": "The prescriber-pharmacist agreement shall contain the following:"}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.03#B", "et": "para", "sc": "10.34.29.03B", "rp": "10|34|29|.03|B.", "x": "Technical modifications to the prescriber-pharmacist agreement shall be reg"}, {"t": "C.", "p": "/us/md/exec/comar/10.34.29.03#C", "et": "para", "sc": "10.34.29.03C", "rp": "10|34|29|.03|C.", "x": "The party designated as the contact person to receive correspondence from t"}, {"t": "D.", "p": "/us/md/exec/comar/10.34.29.03#D", "et": "para", "sc": "10.34.29.03D", "rp": "10|34|29|.03|D.", "x": "If the contact information for the party to the agreement designated to rec"}]}, {"t": ".04 Requirements for Participation in Drug Therapy Management.", "p": "/us/md/exec/comar/10.34.29.04", "et": "section", "sc": "10.34.29.04", "rp": "10|34|29|.04", "sp": "library|Code of Maryland Regulations|10|34|29|.04", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.04#A", "et": "para", "sc": "10.34.29.04A", "rp": "10|34|29|.04|A.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.04#A(1)", "et": "para", "sc": "10.34.29.04A(1)", "rp": "10|34|29|.04|A.|(1)", "x": "Shall be licensed by and in good standing with the Board of Pharmacy;"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.04#A(2)", "et": "para", "sc": "10.34.29.04A(2)", "rp": "10|34|29|.04|A.|(2)", "x": "Shall possess a Doctor of Pharmacy degree or equivalent training as establi"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.04#A(3)", "et": "para", "sc": "10.34.29.04A(3)", "rp": "10|34|29|.04|A.|(3)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#A(3)(a)", "et": "para", "sc": "10.34.29.04A(3)(a)", "rp": "10|34|29|.04|A.|(3)|(a)", "x": "A public final order by the Board of Pharmacy disciplining the pharmacist's"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#A(3)(b)", "et": "para", "sc": "10.34.29.04A(3)(b)", "rp": "10|34|29|.04|A.|(3)|(b)", "x": "Limitations placed on the pharmacist's license by the Board of Pharmacy in "}], "x": "May not have:"}, {"t": "(4)", "p": "/us/md/exec/comar/10.34.29.04#A(4)", "et": "para", "sc": "10.34.29.04A(4)", "rp": "10|34|29|.04|A.|(4)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(a)", "et": "para", "sc": "10.34.29.04A(4)(a)", "rp": "10|34|29|.04|A.|(4)|(a)", "c": [{"t": "(i)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(a)(i)", "et": "para", "sc": "10.34.29.04A(4)(a)(i)", "rp": "10|34|29|.04|A.|(4)|(a)|(i)", "x": "The Board of Pharmacy Specialties;"}, {"t": "(ii)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(a)(ii)", "et": "para", "sc": "10.34.29.04A(4)(a)(ii)", "rp": "10|34|29|.04|A.|(4)|(a)|(ii)", "x": "The American Society of Consultant Pharmacist's Certified Geriatric Practit"}, {"t": "(iii)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(a)(iii)", "et": "para", "sc": "10.34.29.04A(4)(a)(iii)", "rp": "10|34|29|.04|A.|(4)|(a)|(iii)", "x": "Another credentialing body approved by the Board of Pharmacy; or"}], "x": "Certification as a specialist related to the disease state specified by the"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(b)", "et": "para", "sc": "10.34.29.04A(4)(b)", "rp": "10|34|29|.04|A.|(4)|(b)", "c": [{"t": "(i)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(b)(i)", "et": "para", "sc": "10.34.29.04A(4)(b)(i)", "rp": "10|34|29|.04|A.|(4)|(b)|(i)", "x": "A residency accredited by the American Society of Health-Systems Pharmacist"}, {"t": "(ii)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(b)(ii)", "et": "para", "sc": "10.34.29.04A(4)(b)(ii)", "rp": "10|34|29|.04|A.|(4)|(b)|(ii)", "x": "A certificate program approved by the Board of Pharmacy;"}, {"t": "(iii)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(b)(iii)", "et": "para", "sc": "10.34.29.04A(4)(b)(iii)", "rp": "10|34|29|.04|A.|(4)|(b)|(iii)", "x": "A National Association of Boards of Pharmacy credentialing examination; or"}, {"t": "(iv)", "p": "/us/md/exec/comar/10.34.29.04#A(4)(b)(iv)", "et": "para", "sc": "10.34.29.04A(4)(b)(iv)", "rp": "10|34|29|.04|A.|(4)|(b)|(iv)", "x": "An examination approved by the Board of Pharmacy;"}], "x": "Successful completion of:"}], "x": "Shall possess relevant advanced training as indicated by one of the followi"}, {"t": "(5)", "p": "/us/md/exec/comar/10.34.29.04#A(5)", "et": "para", "sc": "10.34.29.04A(5)", "rp": "10|34|29|.04|A.|(5)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#A(5)(a)", "et": "para", "sc": "10.34.29.04A(5)(a)", "rp": "10|34|29|.04|A.|(5)|(a)", "x": "1,000 hours of relevant clinical experience; or"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#A(5)(b)", "et": "para", "sc": "10.34.29.04A(5)(b)", "rp": "10|34|29|.04|A.|(5)|(b)", "x": "320 hours in a structured experience program approved by the Board of Pharm"}], "x": "Shall have successfully completed:"}, {"t": "(6)", "p": "/us/md/exec/comar/10.34.29.04#A(6)", "et": "para", "sc": "10.34.29.04A(6)", "rp": "10|34|29|.04|A.|(6)", "x": "Shall document training related to the disease state specified in the proto"}], "x": "In order to enter into a therapy management contract, a pharmacist:"}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.04#B", "et": "para", "sc": "10.34.29.04B", "rp": "10|34|29|.04|B.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.04#B(1)", "et": "para", "sc": "10.34.29.04B(1)", "rp": "10|34|29|.04|B.|(1)", "x": "Designing, implementing, monitoring, evaluating, and modifying or recommend"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.04#B(2)", "et": "para", "sc": "10.34.29.04B(2)", "rp": "10|34|29|.04|B.|(2)", "x": "Identifying, assessing, and solving medication-related problems, and provid"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.04#B(3)", "et": "para", "sc": "10.34.29.04B(3)", "rp": "10|34|29|.04|B.|(3)", "x": "Conducting appropriate physical assessments, evaluating patient problems, a"}, {"t": "(4)", "p": "/us/md/exec/comar/10.34.29.04#B(4)", "et": "para", "sc": "10.34.29.04B(4)", "rp": "10|34|29|.04|B.|(4)", "x": "Monitoring patients and patient populations regarding the purposes, uses, e"}, {"t": "(5)", "p": "/us/md/exec/comar/10.34.29.04#B(5)", "et": "para", "sc": "10.34.29.04B(5)", "rp": "10|34|29|.04|B.|(5)", "x": "Providing emergency first care, including cardiopulmonary resuscitation;"}, {"t": "(6)", "p": "/us/md/exec/comar/10.34.29.04#B(6)", "et": "para", "sc": "10.34.29.04B(6)", "rp": "10|34|29|.04|B.|(6)", "x": "Using clinical data to optimize therapeutic drug regimens; and"}, {"t": "(7)", "p": "/us/md/exec/comar/10.34.29.04#B(7)", "et": "para", "sc": "10.34.29.04B(7)", "rp": "10|34|29|.04|B.|(7)", "x": "Documenting interventions and evaluating pharmaceutical care outcomes."}], "x": "A pharmacist who does not possess a Doctor of Pharmacy degree shall documen"}, {"t": "C.", "p": "/us/md/exec/comar/10.34.29.04#C", "et": "para", "sc": "10.34.29.04C", "rp": "10|34|29|.04|C.", "x": "The Board of Pharmacy shall determine whether the pharmacist meets the requ"}, {"t": "D.", "p": "/us/md/exec/comar/10.34.29.04#D", "et": "para", "sc": "10.34.29.04D", "rp": "10|34|29|.04|D.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.04#D(1)", "et": "para", "sc": "10.34.29.04D(1)", "rp": "10|34|29|.04|D.|(1)", "x": "The prescriber-pharmacist agreement;"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.04#D(2)", "et": "para", "sc": "10.34.29.04D(2)", "rp": "10|34|29|.04|D.|(2)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#D(2)(a)", "et": "para", "sc": "10.34.29.04D(2)(a)", "rp": "10|34|29|.04|D.|(2)|(a)", "x": "Prescriber-pharmacist agreement; or"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#D(2)(b)", "et": "para", "sc": "10.34.29.04D(2)(b)", "rp": "10|34|29|.04|D.|(2)|(b)", "x": "Protocols specified in the prescriber-pharmacist agreement; and"}], "x": "Subsequent amendments made to the:"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.04#D(3)", "et": "para", "sc": "10.34.29.04D(3)", "rp": "10|34|29|.04|D.|(3)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#D(3)(a)", "et": "para", "sc": "10.34.29.04D(3)(a)", "rp": "10|34|29|.04|D.|(3)|(a)", "x": "Prescriber-pharmacist agreement; or"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#D(3)(b)", "et": "para", "sc": "10.34.29.04D(3)(b)", "rp": "10|34|29|.04|D.|(3)|(b)", "x": "Protocols specified in the prescriber-pharmacist agreement."}], "x": "Changes to participants of the:"}], "x": "An authorized prescriber who has entered into a prescriber-pharmacist agree"}, {"t": "E.", "p": "/us/md/exec/comar/10.34.29.04#E", "et": "para", "sc": "10.34.29.04E", "rp": "10|34|29|.04|E.", "x": "The Boards that regulate the authorized prescriber shall notify the authori"}, {"t": "F.", "p": "/us/md/exec/comar/10.34.29.04#F", "et": "para", "sc": "10.34.29.04F", "rp": "10|34|29|.04|F.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.04#F(1)", "et": "para", "sc": "10.34.29.04F(1)", "rp": "10|34|29|.04|F.|(1)", "x": "The prescriber-pharmacist agreement;"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.04#F(2)", "et": "para", "sc": "10.34.29.04F(2)", "rp": "10|34|29|.04|F.|(2)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#F(2)(a)", "et": "para", "sc": "10.34.29.04F(2)(a)", "rp": "10|34|29|.04|F.|(2)|(a)", "x": "Prescriber-pharmacist agreement; or"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#F(2)(b)", "et": "para", "sc": "10.34.29.04F(2)(b)", "rp": "10|34|29|.04|F.|(2)|(b)", "x": "Protocols specified in the prescriber-pharmacist agreement; and"}], "x": "Subsequent amendments made to the:"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.04#F(3)", "et": "para", "sc": "10.34.29.04F(3)", "rp": "10|34|29|.04|F.|(3)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.04#F(3)(a)", "et": "para", "sc": "10.34.29.04F(3)(a)", "rp": "10|34|29|.04|F.|(3)|(a)", "x": "Prescriber-pharmacist agreement; or"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.04#F(3)(b)", "et": "para", "sc": "10.34.29.04F(3)(b)", "rp": "10|34|29|.04|F.|(3)|(b)", "x": "Protocols specified in the prescriber-pharmacist agreement."}], "x": "Changes to participants of the:"}], "x": "A licensed pharmacist who has entered into a prescriber-pharmacist agreemen"}, {"t": "G.", "p": "/us/md/exec/comar/10.34.29.04#G", "et": "para", "sc": "10.34.29.04G", "rp": "10|34|29|.04|G.", "x": "The Board of Pharmacy shall determine whether a pharmacist added under \u00a7F o"}, {"t": "H.", "p": "/us/md/exec/comar/10.34.29.04#H", "et": "para", "sc": "10.34.29.04H", "rp": "10|34|29|.04|H.", "x": "The Board of Pharmacy shall notify the pharmacist of any additional informa"}]}, {"t": ".05 Guidelines for Use of Protocols.", "p": "/us/md/exec/comar/10.34.29.05", "et": "section", "sc": "10.34.29.05", "rp": "10|34|29|.05", "sp": "library|Code of Maryland Regulations|10|34|29|.05", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.05#A", "et": "para", "sc": "10.34.29.05A", "rp": "10|34|29|.05|A.", "x": "On receipt of specific instructions from the authorized prescriber regardin"}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.05#B", "et": "para", "sc": "10.34.29.05B", "rp": "10|34|29|.05|B.", "x": "The protocol may not prohibit the pharmacist from providing other pharmaceu"}, {"t": "C.", "p": "/us/md/exec/comar/10.34.29.05#C", "et": "para", "sc": "10.34.29.05C", "rp": "10|34|29|.05|C.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.05#C(1)", "et": "para", "sc": "10.34.29.05C(1)", "rp": "10|34|29|.05|C.|(1)", "x": "Authorized prescriber; and"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.05#C(2)", "et": "para", "sc": "10.34.29.05C(2)", "rp": "10|34|29|.05|C.|(2)", "x": "Pharmacist."}], "x": "Documentation of activities performed under a protocol or the authorized pr"}, {"t": "D.", "p": "/us/md/exec/comar/10.34.29.05#D", "et": "para", "sc": "10.34.29.05D", "rp": "10|34|29|.05|D.", "x": "Documentation may be maintained in written or electronic form."}, {"t": "E.", "p": "/us/md/exec/comar/10.34.29.05#E", "et": "para", "sc": "10.34.29.05E", "rp": "10|34|29|.05|E.", "x": "Oral communications between the authorized prescriber and pharmacist shall "}, {"t": "F.", "p": "/us/md/exec/comar/10.34.29.05#F", "et": "para", "sc": "10.34.29.05F", "rp": "10|34|29|.05|F.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.05#F(1)", "et": "para", "sc": "10.34.29.05F(1)", "rp": "10|34|29|.05|F.|(1)", "x": "Modifies the dose or agent under the therapy management contract;"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.05#F(2)", "et": "para", "sc": "10.34.29.05F(2)", "rp": "10|34|29|.05|F.|(2)", "x": "Detects an abnormal result from an assessment activity; or"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.05#F(3)", "et": "para", "sc": "10.34.29.05F(3)", "rp": "10|34|29|.05|F.|(3)", "x": "Initiates drug therapy under a written, disease-state specific protocol, fo"}], "x": "Unless an alternative time period is stated in the prescriber-pharmacist ag"}]}, {"t": ".06 Therapy Management Contracts.", "p": "/us/md/exec/comar/10.34.29.06", "et": "section", "sc": "10.34.29.06", "rp": "10|34|29|.06", "sp": "library|Code of Maryland Regulations|10|34|29|.06", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.06#A", "et": "para", "sc": "10.34.29.06A", "rp": "10|34|29|.06|A.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.06#A(1)", "et": "para", "sc": "10.34.29.06A(1)", "rp": "10|34|29|.06|A.|(1)", "x": "Authorized prescriber or authorized prescribers involved in the management "}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.06#A(2)", "et": "para", "sc": "10.34.29.06A(2)", "rp": "10|34|29|.06|A.|(2)", "x": "Pharmacist or pharmacists involved in the management of the patient under a"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.06#A(3)", "et": "para", "sc": "10.34.29.06A(3)", "rp": "10|34|29|.06|A.|(3)", "x": "Patient receiving care under the therapy management contract."}], "x": "A therapy management contract shall be signed by the:"}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.06#B", "et": "para", "sc": "10.34.29.06B", "rp": "10|34|29|.06|B.", "c": [{"t": "(1)", "p": "/us/md/exec/comar/10.34.29.06#B(1)", "et": "para", "sc": "10.34.29.06B(1)", "rp": "10|34|29|.06|B.|(1)", "x": "A list of allowable substitutions of chemically dissimilar drugs, if any;"}, {"t": "(2)", "p": "/us/md/exec/comar/10.34.29.06#B(2)", "et": "para", "sc": "10.34.29.06B(2)", "rp": "10|34|29|.06|B.|(2)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(a)", "et": "para", "sc": "10.34.29.06B(2)(a)", "rp": "10|34|29|.06|B.|(2)|(a)", "c": [{"t": "(i)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(a)(i)", "et": "para", "sc": "10.34.29.06B(2)(a)(i)", "rp": "10|34|29|.06|B.|(2)|(a)|(i)", "x": "Coerced into participating in the therapy management contract;"}, {"t": "(ii)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(a)(ii)", "et": "para", "sc": "10.34.29.06B(2)(a)(ii)", "rp": "10|34|29|.06|B.|(2)|(a)|(ii)", "x": "Given economic incentives, excluding normal reimbursement for services rend"}, {"t": "(iii)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(a)(iii)", "et": "para", "sc": "10.34.29.06B(2)(a)(iii)", "rp": "10|34|29|.06|B.|(2)|(a)|(iii)", "x": "Involuntarily required to participate in the therapy management contract; a"}], "x": "None of the parties involved in the therapy management contract have been:"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(b)", "et": "para", "sc": "10.34.29.06B(2)(b)", "rp": "10|34|29|.06|B.|(2)|(b)", "c": [{"t": "(i)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(b)(i)", "et": "para", "sc": "10.34.29.06B(2)(b)(i)", "rp": "10|34|29|.06|B.|(2)|(b)|(i)", "x": "Modifies the dose or agent under the therapy management contract; or"}, {"t": "(ii)", "p": "/us/md/exec/comar/10.34.29.06#B(2)(b)(ii)", "et": "para", "sc": "10.34.29.06B(2)(b)(ii)", "rp": "10|34|29|.06|B.|(2)|(b)|(ii)", "x": "Detects an abnormal result from an assessment activity;"}], "x": "The pharmacist shall notify the authorized prescriber under the terms of th"}], "x": "A statement that:"}, {"t": "(3)", "p": "/us/md/exec/comar/10.34.29.06#B(3)", "et": "para", "sc": "10.34.29.06B(3)", "rp": "10|34|29|.06|B.|(3)", "c": [{"t": "(a)", "p": "/us/md/exec/comar/10.34.29.06#B(3)(a)", "et": "para", "sc": "10.34.29.06B(3)(a)", "rp": "10|34|29|.06|B.|(3)|(a)", "x": "That the patient may terminate the therapy management contract at any time;"}, {"t": "(b)", "p": "/us/md/exec/comar/10.34.29.06#B(3)(b)", "et": "para", "sc": "10.34.29.06B(3)(b)", "rp": "10|34|29|.06|B.|(3)|(b)", "x": "The procedure by which the patient may terminate the therapy management con"}], "x": "Notice to the patient stating:"}, {"t": "(4)", "p": "/us/md/exec/comar/10.34.29.06#B(4)", "et": "para", "sc": "10.34.29.06B(4)", "rp": "10|34|29|.06|B.|(4)", "x": "A procedure for periodic review by the authorized prescriber of the drugs m"}, {"t": "(5)", "p": "/us/md/exec/comar/10.34.29.06#B(5)", "et": "para", "sc": "10.34.29.06B(5)", "rp": "10|34|29|.06|B.|(5)", "x": "A reference to the protocol or protocols under which the pharmacist shall a"}, {"t": "(6)", "p": "/us/md/exec/comar/10.34.29.06#B(6)", "et": "para", "sc": "10.34.29.06B(6)", "rp": "10|34|29|.06|B.|(6)", "x": "Exceptions or limitations to the protocol or protocols for the specific pat"}], "x": "A therapy management contract shall contain:"}]}, {"t": ".07 Fees.", "p": "/us/md/exec/comar/10.34.29.07", "et": "section", "sc": "10.34.29.07", "rp": "10|34|29|.07", "sp": "library|Code of Maryland Regulations|10|34|29|.07", "c": [{"t": "A.", "p": "/us/md/exec/comar/10.34.29.07#A", "et": "para", "sc": "10.34.29.07A", "rp": "10|34|29|.07|A.", "x": "Scope. This regulation governs authorized prescribers and pharmacists parti"}, {"t": "B.", "p": "/us/md/exec/comar/10.34.29.07#B", "et": "para", "sc": "10.34.29.07B", "rp": "10|34|29|.07|B.", "x": "Fees. The Board of Pharmacy requires a fee for the prescriber-pharmacist ag"}]}]}